Lv1
40 积分 2025-06-09 加入
Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR Variations in Concurrent TP53 Mutations: Research Summary
23天前
已完结
Adenocarcinoma transformed into squamous cell carcinoma in non-small cell lung cancer
1个月前
已完结
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
3个月前
已完结
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
6个月前
已完结
Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics
7个月前
已完结
Characterization of Cardiovascular Events and Prognosis in Immune Checkpoint Inhibitor–Related Myocarditis
9个月前
已完结
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
10个月前
已完结
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
10个月前
已完结
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go
10个月前
已完结
Immune Checkpoint Inhibitor–Induced Cardiotoxicity
1年前
已完结
皖公网安备34019202002308
